SCHEMBL4257732

SCHEMBL4257732

COc1cc(O)cc(OC)c1CCC(=O)O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.50
MAPT P10636 2/20 0.45
CYP3A4 P08684 1/20 0.45
SYNJ2 O15056 1/20 0.45
FFAR1 O14842 2/20 0.44
FFAR4 Q5NUL3 1/20 0.44
CYP19A1 P11511 1/20 0.44
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
KCNA3 P22001 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
APP P05067 1/20 0.42
LMNA P02545 1/20 0.42
LTB4R Q15722 1/20 0.42
LTB4R2 Q9NPC1 1/20 0.42
KDM4E B2RXH2 1/20 0.41
ALDH1A1 P00352 1/20 0.41
HPGD P15428 1/20 0.41
HSD17B10 Q99714 1/20 0.41
GPR17 Q13304 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29140671 0.85 ALDH1A1 (0.46) POLBMAPTFFAR1FFAR4NPSR1
SCHEMBL491024 0.85 POLB (0.50) POLBCYP3A4FFAR1KDM4EALDH1A1
SCHEMBL145533 0.82 TSHR (0.50) POLBFFAR1FFAR4APPLMNA
SCHEMBL146097 0.81 ALDH1A1 (0.47) POLBFFAR1NPSR1LTB4RLTB4R2
SCHEMBL1745586 0.80 KDM4E (0.47) POLBCYP3A4MEN1KMT2AKDM4E
SCHEMBL28599061 0.79 CYP19A1 (0.49) MAPTCYP3A4SYNJ2CYP19A1MEN1
SCHEMBL28797366 0.78 POLB (0.41) POLBMAPTFFAR1FFAR4LMNA
SCHEMBL7194539 0.78 MEN1 (0.55) POLBCYP3A4SYNJ2CYP19A1MEN1
SCHEMBL4841064 0.77 POLB (0.62) POLBFFAR1MEN1KMT2ANPSR1
SCHEMBL7189194 0.77 CYP3A4 (0.58) MAPTCYP3A4SYNJ2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1559422-B1 RECEPTOR FUNCTION CONTROLLING AGENT TAKEDA PHARMACEUTICAL (JP) 2014-04-30 EP disclosed
US-20090012093-A1 Receptor Function Regulator TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-01-08 US disclosed
EP-1559422-A1 RECEPTOR FUNCTION CONTROLLING AGENT Takeda Pharmaceutical Company Limited (JP) 2005-08-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090012093-A1 Receptor Function Regulator GPR119, GIPR, INSR POLB 4877/4885MAPT 4718/4885CYP3A4 3431/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.